ICVX
Price:
$15.31
Market Cap:
$769.04M
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was i...[Read more]
Industry
Biotechnology
IPO Date
2021-07-29
Stock Exchange
NASDAQ
Ticker
ICVX
According to Icosavax, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.96. This represents a change of 86.58% compared to the average of -3.73 of the last 4 quarters.
The mean historical PE Ratio of Icosavax, Inc. over the last ten years is -20.94. The current -6.96 PE Ratio has changed 3.22% with respect to the historical average. Over the past ten years (40 quarters), ICVX's PE Ratio was at its highest in in the September 2022 quarter at -1.51. The PE Ratio was at its lowest in in the March 2020 quarter at -38.32.
Average
-20.94
Median
-5.65
Minimum
-68.92
Maximum
-3.57
Discovering the peaks and valleys of Icosavax, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 15.23%
Maximum Annual PE Ratio = -3.57
Minimum Annual Increase = -92.39%
Minimum Annual PE Ratio = -68.92
Year | PE Ratio | Change |
---|---|---|
2022 | -3.57 | -41.01% |
2021 | -6.05 | 15.23% |
2020 | -5.25 | -92.39% |
The current PE Ratio of Icosavax, Inc. (ICVX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.95
5-year avg
-20.94
10-year avg
-20.94
Icosavax, Inc.’s PE Ratio is less than Terns Pharmaceuticals, Inc. (-5.12), less than Amylyx Pharmaceuticals, Inc. (-1.38), less than Acumen Pharmaceuticals, Inc. (-1.74), less than Inozyme Pharma, Inc. (-1.84), less than X4 Pharmaceuticals, Inc. (-4.05), greater than Day One Biopharmaceuticals, Inc. (-15.73), less than Eledon Pharmaceuticals, Inc. (17.15), less than HOOKIPA Pharma Inc. (-0.62), greater than Mereo BioPharma Group plc (-13.56), less than PDS Biotechnology Corporation (-1.90), less than Immix Biopharma, Inc. (-2.41), less than CNS Pharmaceuticals, Inc. (-0.16), less than Hepion Pharmaceuticals, Inc. (-0.20), less than Freeline Therapeutics Holdings plc (-1.01), less than AVROBIO, Inc. (2.07),
Company | PE Ratio | Market cap |
---|---|---|
-5.12 | $491.80M | |
-1.38 | $361.25M | |
-1.74 | $142.39M | |
-1.84 | $180.51M | |
-4.05 | $57.64M | |
-15.73 | $1.38B | |
17.15 | $239.55M | |
-0.62 | $20.76M | |
-13.56 | $575.61M | |
-1.90 | $78.19M | |
-2.41 | $49.14M | |
-0.16 | $7.15M | |
-0.20 | $4.62M | |
-1.01 | $28.28M | |
2.07 | $5.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Icosavax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Icosavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Icosavax, Inc.'s PE Ratio?
How is the PE Ratio calculated for Icosavax, Inc. (ICVX)?
What is the highest PE Ratio for Icosavax, Inc. (ICVX)?
What is the 3-year average PE Ratio for Icosavax, Inc. (ICVX)?
What is the 5-year average PE Ratio for Icosavax, Inc. (ICVX)?
How does the current PE Ratio for Icosavax, Inc. (ICVX) compare to its historical average?